U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07649174) titled 'Cadonilimab Plus Chemotherapy in LACC: A Prospective, Multicenter, Randomized Phase II Trial' on June 11.
Brief Summary: This is a prospective, multi-center, randomized controlled phase II clinical trial aimed at exploring the efficacy evaluation of cadilonilumab immunotherapy combined with chemotherapy for locally advanced cervical cancer.
Study Start Date: June 06
Study Type: INTERVENTIONAL
Condition:
Cervical Cancer
Intervention:
PROCEDURE: Neoadjuvant Therapy Plus Surgery
Patients received three cycles of neoadjuvant cadonilimab plus chemotherapy. Patients subsequently underwent radical hysterectomy with pelvic lymphadene...